The up-regulation of CTGF reduced chemotherapy-induced apoptosis in breast cancer by increasing the expression of bcl-xl and cellular inhibitor of apoptosis proteins (cIAP1) [22]. The gene discussed is BCL2L1; the disease is breast carcinoma.